SARS-CoV-2 (COVID-19) Envelope Antibody (biotin)

Supplier: Gentaur

0.01 GBP
Catalog: 223-3531-biotin-01mg Stock:On request
Product Size: 0.1 mg

You may also be interested


Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. Envelope protein is a small polypeptide that contains at least one alpha-helical transmembrane domain. It involves in several aspects of the virus's life cycle, such as assembly, budding, envelope formation, and pathogenesis. E protein has membrane permeabilizing activity, which provides a possible rationale to inhibit in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication (3).



Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.


  • SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody can be stored at 4 ˚
  • C for three months and -20 ˚
  • C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.


  • Research area: Infectious Disease, COVID-19
  • Host species: Rabbit
  • Species reactivity: Virus
  • Homology: Predicted reactivity based on immunogen sequence: SARS-CoV Envelope proteins: (100%)
  • Immunogen: Anti-SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope antibody (3531) was raised against a peptide corresponding to 10 amino acids near the amino terminus of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope protein.
  • The immunogen is located within the first 50 amino acids of SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope.
  • Tested Applications: E, IHC
  • Applications: IHC: 2 μ
  • g/mL
  • Antibody validated: Immunohistochemistry in COVID-19 patient samples. All other applications and species not yet tested.
  • Specificity: N/A
  • Positive control 1: N/A
  • Positive control 2: N/A
  • Positive control 3: N/A
  • Positive control 4: N/A
  • Positive control 5: N/A
  • Positive control 6: N/A
  • Predicted molecular weight: N/A
  • MW explanation: N/A
  • Validation: N/A
  • Isoforms: SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope has one isoform (75aa).
  • Purification: SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody is affinity chromatography purified via peptide column.
  • Clonality: Polyclonal
  • Clone: N/A
  • Isotype: IgG
  • Conjugate: Biotin
  • Physical state: Liquid
  • Buffer: SARS-CoV-2 (COVID-19, 2019-nCoV) Envelope Antibody is supplied in PBS containing 0.02% sodium azide.
  • Concentration: 1 mg/mL
  • NCBI official symbol: E
  • Accession #: QHD43418
  • Protein GI #: 1791269092
  • NCBI gene ID#: 43740570
  • NCBI official full name: envelope protein
  • NCBI organism: Wuhan seafood market pneumonia virus
  • SWISSPROT #: QHD43418

Optimal dilutions for each application to be determined by the researcher.

0 reviews for ProSci

Add a review

Your email address will not be published.